Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 21 Nov 2014
At a glance
- Drugs Trastuzumab (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil; Paclitaxel
- Indications Breast cancer; Early breast cancer
- Focus Therapeutic Use
- 11 Aug 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 11 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2011 Planned end date changed from 1 Apr 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.